multimmune GmbH

..........delivering innovative cancer theranostics


multimmune's platform technologies have been fully evaluated in the pre-clinical setting, and the data published widely in the international, peer-reviewed literature.

A full list of publications relating to the membrane form of Hsp70 and the use of this discovery for the development of new diagnostic and therapeutic approaches can be seen by clicking HERE